Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-25-075699
Filing Date
2025-04-08
Accepted
2025-04-08 16:06:46
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d664816ddefa14a.htm DEFA14A 11685
2 GRAPHIC g664816g66a03.jpg GRAPHIC 399435
3 GRAPHIC g664816g66a04.jpg GRAPHIC 137790
  Complete submission text file 0001193125-25-075699.txt   752728
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 25821985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)